$OWLT
Owlet, Inc. Stock $owlt

$owlt Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000162828022007346 Filed on March 25, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	-$2.500M	$75.84M	$0.00
YoY Change		0.58%
Cost Of Revenue	$3.500M	$40.78M	$10.83M
YoY Change	-67.68%	3.18%
Gross Profit	-$6.000M	$35.06M	$10.17M
YoY Change	-159.0%	-2.28%
Gross Profit Margin		46.23%
Selling, General & Admin	$20.10M	$69.42M	$444.1K
YoY Change	4425.7%	114.25%
% of Gross Profit		198.02%	4.37%
Research & Development	$7.200M	$21.43M	$2.830M
YoY Change	154.42%	104.75%
% of Gross Profit		61.12%	27.83%
Depreciation & Amortization	$334.0K	$1.133M	$250.0K
YoY Change	33.6%	29.78%
% of Gross Profit		3.23%	2.46%
Operating Expenses	$27.30M	$90.85M	$444.1K
YoY Change	6046.85%	111.93%
Operating Profit	-$33.30M	-$55.79M	$9.726M
YoY Change	-442.39%	698.05%
Interest Expense	-$400.0K	$1.772M	-$7.193M
YoY Change	-94.44%	28.22%
% of Operating Profit			-73.96%
Other Income/Expense, Net	$9.700M	-$15.88M	-$2.210M
YoY Change	-538.91%	352.45%
Pretax Income	-$24.00M	-$71.67M	-$8.217M
YoY Change	192.08%	582.53%
Income Tax	$0.00	$31.00K	$0.00
% Of Pretax Income
Net Earnings	-$24.00M	-$71.70M	-$8.217M
YoY Change	192.08%	581.53%
Net Earnings / Revenue		-94.54%
Basic Earnings Per Share		-$1.13
Diluted Earnings Per Share	-$219.1K	-$1.13	-$298.9K
COMMON SHARES
Basic Shares Outstanding	112.8M	63.22M shares
Diluted Shares Outstanding		63.22M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.10M	$95.10M	$1.287M
YoY Change	7287.96%	7287.96%
Cash & Equivalents	$95.05M	$95.10M	$17.01M
Short-Term Investments
Other Short-Term Assets	$12.20M	$12.20M	$93.00K
YoY Change	13018.28%	4354.99%
Inventory	$17.98M	$18.00M	$7.912M
Prepaid Expenses			$163.0K
Receivables	$10.47M	$10.50M	$10.53M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$135.8M	$135.8M	$37.61M
YoY Change	261.08%	8599.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.870M	$1.900M	$1.718M
YoY Change	8.85%	10.59%
Goodwill
YoY Change
Intangibles			$605.0K
YoY Change
Long-Term Investments			$230.1M
YoY Change
Other Assets	$600.0K	$600.0K
YoY Change		231.49%
Total Long-Term Assets	$4.232M	$4.200M	$2.504M
YoY Change	69.01%	-98.17%
TOTAL ASSETS
Total Short-Term Assets	$135.8M	$135.8M	$37.61M
Total Long-Term Assets	$4.232M	$4.200M	$2.504M
Total Assets	$140.0M	$140.0M	$40.12M
YoY Change	249.09%	-39.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.77M	$27.80M	$16.38M
YoY Change	69.52%	69.73%
Accrued Expenses	$31.73M	$31.70M	$10.59M
YoY Change	199.57%	9952.96%
Deferred Revenue	$1.061M		$1.643M
YoY Change	-35.42%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.534M	$8.500M	$2.024M
YoY Change	321.64%	319.96%
Total Short-Term Liabilities	$69.09M	$69.10M	$47.27M
YoY Change	46.15%	21813.55%
LONG-TERM LIABILITIES
Long-Term Debt	$7.993M	$8.000M	$10.18M
YoY Change	-21.48%
Other Long-Term Liabilities	$712.0K	$7.700M	$494.0K
YoY Change	44.13%	-75.62%
Total Long-Term Liabilities	$8.705M	$15.70M	$10.67M
YoY Change	-18.45%	-50.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$69.09M	$69.10M	$47.27M
Total Long-Term Liabilities	$8.705M	$15.70M	$10.67M
Total Liabilities	$84.86M	$84.80M	$60.94M
YoY Change	39.25%	165.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$143.4M		-$71.72M
YoY Change	99.98%
Common Stock	$11.00K		$2.000K
YoY Change	450.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.19M	$55.20M	-$68.01M
YoY Change
Total Liabilities & Shareholders Equity	$140.0M	$140.0M	$40.12M
YoY Change	249.09%	-39.55%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$24.00M	-$71.70M	-$8.217M
YoY Change	192.08%	581.53%
Depreciation, Depletion And Amortization	$334.0K	$1.133M	$250.0K
YoY Change	33.6%	29.78%
Cash From Operating Activities	-$5.897M	-$40.56M	-$133.4K
YoY Change	4321.87%	31338.76%
INVESTING ACTIVITIES
Capital Expenditures	-$460.0K	$969.0K	$120.0K
YoY Change	-483.33%	0.21%
Acquisitions
YoY Change
Other Investing Activities	-$2.000M	-$2.000M	$0.00
YoY Change		-99.13%
Cash From Investing Activities	-$440.0K	-$2.020M	$0.00
YoY Change		91.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$1.000M
YoY Change
Cash From Financing Activities	-13.55M	$120.6M	-18.03K
YoY Change	75052.52%	1767.78%
NET CHANGE
Cash From Operating Activities	-5.897M	-$40.56M	-133.4K
Cash From Investing Activities	-440.0K	-$2.020M	0.000
Cash From Financing Activities	-13.55M	$120.6M	-18.03K
Net Change In Cash	-19.89M	$78.05M	-151.4K
YoY Change	13036.27%	1380.09%
FREE CASH FLOW
Cash From Operating Activities	-$5.897M	-$40.56M	-$133.4K
Capital Expenditures	-$460.0K	$969.0K	$120.0K
Free Cash Flow	-$5.437M	-$41.53M	-$253.4K
YoY Change	2045.96%	3688.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001816708
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Entity Registrant Name EntityRegistrantName	Owlet, Inc.
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-39516
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1615012
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2500 Executive Parkway
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 500
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Lehi
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
CY2021	dei	City Area Code CityAreaCode	844
CY2021	dei	Local Phone Number LocalPhoneNumber	334-5330
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	229500000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	113067484	shares
CY2021	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95054000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17009000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	403000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	201000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10468000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10525000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	17980000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	7912000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12313000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2168000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	135815000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	37614000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1870000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1696000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	605000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	666000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	181000	USD
CY2021Q4	us-gaap	Assets Assets	140047000	USD
CY2020Q4	us-gaap	Assets Assets	40118000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	27765000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	16379000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31730000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10592000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1061000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1643000	USD
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9700000	USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	6934000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8534000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2024000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	69090000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47272000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7993000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10180000	USD
CY2021Q4	owlt	Preferred Stock Warrant Liability PreferredStockWarrantLiability	0	USD
CY2020Q4	owlt	Preferred Stock Warrant Liability PreferredStockWarrantLiability	2993000	USD
CY2021Q4	owlt	Common Stock Warrant Liability CommonStockWarrantLiability	7061000	USD
CY2020Q4	owlt	Common Stock Warrant Liability CommonStockWarrantLiability	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	712000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	494000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	84856000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	60939000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	52000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112996568	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	112996568	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22118619	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22118619	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	11000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	198602000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3707000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-143422000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-71718000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55191000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-68009000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	140047000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40118000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75842000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75403000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40784000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39526000	USD
CY2021	us-gaap	Gross Profit GrossProfit	35058000	USD
CY2020	us-gaap	Gross Profit GrossProfit	35877000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32339000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13140000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	37084000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19263000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21427000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10465000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	90850000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	42868000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-55792000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-6991000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2098000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Interest Expense InterestExpense	1772000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1382000	USD
CY2021	owlt	Interest Expense From Contingent Beneficial Conversion Feature InterestExpenseFromContingentBeneficialConversionFeature	26061000	USD
CY2020	owlt	Interest Expense From Contingent Beneficial Conversion Feature InterestExpenseFromContingentBeneficialConversionFeature	0	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5578000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1952000	USD
CY2021	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	15745000	USD
CY2020	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	0	USD
CY2021	owlt	Other Income Expense Net OtherIncomeExpenseNet	-313000	USD
CY2020	owlt	Other Income Expense Net OtherIncomeExpenseNet	-176000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15881000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3510000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71673000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10501000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-71704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10521000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63216912	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63216912	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21956848	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21956848	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-58902000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	226000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-567000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-68009000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	47188000	USD
CY2021	owlt	Stock Issued During Period Value Conversion Of Convertible Securities In Connection With Reverse Recapitalization StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesInConnectionWithReverseRecapitalization	7122000	USD
CY2021	owlt	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature In Connection With Reverse Recapitalization AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureInConnectionWithReverseRecapitalization	26061000	USD
CY2021	owlt	Conversion Of Preferred Stock Warrants And Common Stock Warrants In Connection With The Reverse Recapitalization ConversionOfPreferredStockWarrantsAndCommonStockWarrantsInConnectionWithTheReverseRecapitalization	8571000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2962000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	118000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1070000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10521000	USD
CY2021	owlt	Reverse Recapitalization Transaction Net Of Fees ReverseRecapitalizationTransactionNetOfFees	101261000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	442000	USD
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4259000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-71704000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55191000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-71704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10521000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1133000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10493000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	989000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11649000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4259000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3468000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32117000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11818000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	873000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2098000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1070000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1581000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	417000	USD
CY2021	owlt	Interest Expense From Contingent Beneficial Conversion Feature InterestExpenseFromContingentBeneficialConversionFeature	26061000	USD
CY2020	owlt	Interest Expense From Contingent Beneficial Conversion Feature InterestExpenseFromContingentBeneficialConversionFeature	0	USD
CY2021	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	15745000	USD
CY2020	owlt	Change In Fair Value Of Common Stock Warrantliability ChangeInFairValueOfCommonStockWarrantliability	0	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5578000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1952000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-725000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-391000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	144000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3000000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	957000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-390000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-333000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40556000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-129000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	969000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	967000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1051000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	89000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2020000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1056000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	13708000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	12953000	USD
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	21194000	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	11687000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5000000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021	owlt	Proceeds From Paycheck Protection Program Loan Cares Act Of Two Thousand And Twenty ProceedsFromPaycheckProtectionProgramLoanCARESActOfTwoThousandAndTwenty	0	USD
CY2020	owlt	Proceeds From Paycheck Protection Program Loan Cares Act Of Two Thousand And Twenty ProceedsFromPaycheckProtectionProgramLoanCARESActOfTwoThousandAndTwenty	2075000	USD
CY2021	owlt	Deferred Transaction Financing Costs Net DeferredTransactionFinancingCostsNet	11610000	USD
CY2020	owlt	Deferred Transaction Financing Costs Net DeferredTransactionFinancingCostsNet	0	USD
CY2021	owlt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	133889000	USD
CY2020	owlt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	USD
CY2021	owlt	Payments For Cash Payout Of Stock Options Upon Merger PaymentsForCashPayoutOfStockOptionsUponMerger	9890000	USD
CY2020	owlt	Payments For Cash Payout Of Stock Options Upon Merger PaymentsForCashPayoutOfStockOptionsUponMerger	0	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	108000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	117000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	120621000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6458000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	78045000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5273000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17009000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11736000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95054000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17009000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	47188000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	owlt	Conversion Of Related Party Convertible Notes To Common Stock ConversionOfRelatedPartyConvertibleNotesToCommonStock	33183000	USD
CY2020	owlt	Conversion Of Related Party Convertible Notes To Common Stock ConversionOfRelatedPartyConvertibleNotesToCommonStock	0	USD
CY2021	owlt	Common Stock Warrants Received Of Merger CommonStockWarrantsReceivedOfMerger	22806000	USD
CY2020	owlt	Common Stock Warrants Received Of Merger CommonStockWarrantsReceivedOfMerger	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Key management estimates include those related to revenue recognition (including standalone selling price, usage period of hardware products sold, sales incentives, product returns and implied post contract support and service), allowances for doubtful accounts, write-downs for obsolete or slow-moving inventory, useful lives for property and equipment, impairment assessments for long-lived tangible and intangible assets, warranty obligations, the contingent beneficial conversion feature, valuation allowances for net deferred income tax assets, uncertain tax positions, and valuation of warrants and stock-based compensation.</span></div>
CY2021	owlt	Contract With Customer Contra Revenue Customer Returns ContractWithCustomerContraRevenueCustomerReturns	23164000	USD
CY2021	owlt	Contract With Customer Reduction To Cost Of Revenues Customer Returns ContractWithCustomerReductionToCostOfRevenuesCustomerReturns	8151000	USD
CY2021Q4	owlt	Sales Returns Not Yet Received SalesReturnsNotYetReceived	6701000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-143422000	USD
CY2021	owlt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	133889000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1696000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	329000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	605000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	183000	USD
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	1101000	USD
CY2021Q3	owlt	Total Shares Of Common Stock Immediately After Business Combination TotalSharesOfCommonStockImmediatelyAfterBusinessCombination	112783800	shares
CY2020Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	0	USD
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	USD
CY2021	owlt	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	27086000	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	15317000	USD
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	496717	shares
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	9890000	USD
CY2021Q3	owlt	Owlet Equityholders Common Stock OwletEquityholdersCommonStock	90824573	shares
CY2021Q3	owlt	Owlet Equity Holders Common Stock Percentage OwletEquityHoldersCommonStockPercentage	0.81
CY2021Q3	owlt	Share Of Sponsor And Related Parties ShareOfSponsorAndRelatedParties	5750000	shares
CY2021Q3	owlt	Percentage Of Sponsor And Related Parties Shares PercentageOfSponsorAndRelatedPartiesShares	0.05
CY2021Q3	owlt	Percentage Of Total Shares Of Common Stock Immediately After Business Combination PercentageOfTotalSharesOfCommonStockImmediatelyAfterBusinessCombination	1
CY2021	owlt	Gross Proceeds From Merger GrossProceedsFromMerger	145499000	USD
CY2021Q3	owlt	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	133889000	USD
CY2021	owlt	Common Stock Warrants Received Of Merger CommonStockWarrantsReceivedOfMerger	22806000	USD
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	9890000	USD
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	66000	USD
CY2021	owlt	Deferred Transaction Financing Costs Net DeferredTransactionFinancingCostsNet	11610000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3776000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2736000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1906000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1018000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1870000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718000	USD
CY2021Q4	owlt	Accrued Sales Return Current AccruedSalesReturnCurrent	21179000	USD
CY2020Q4	owlt	Accrued Sales Return Current AccruedSalesReturnCurrent	2844000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	924000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	378000	USD
CY2021	owlt	Provision For Warranties Issued During The Period ProvisionForWarrantiesIssuedDuringThePeriod	584000	USD
CY2020	owlt	Provision For Warranties Issued During The Period ProvisionForWarrantiesIssuedDuringThePeriod	1840000	USD
CY2021	owlt	Settlements Of Warranty Claims During The Period SettlementsOfWarrantyClaimsDuringThePeriod	847000	USD
CY2020	owlt	Settlements Of Warranty Claims During The Period SettlementsOfWarrantyClaimsDuringThePeriod	1294000	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	661000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	924000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1802000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	845000	USD
CY2021	owlt	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	3554000	USD
CY2020	owlt	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	3319000	USD
CY2021	owlt	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	4121000	USD
CY2020	owlt	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	2362000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1235000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1802000	USD
CY2021	owlt	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	1644000	USD
CY2020	owlt	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	746000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	16534000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	12395000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8534000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2024000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	191000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7993000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10180000	USD
CY2021Q4	owlt	Long Term Debt Future Aggregate Maturity Year One LongTermDebtFutureAggregateMaturityYearOne	8534000	USD
CY2021Q4	owlt	Long Term Debt Future Aggregate Maturity Year Two LongTermDebtFutureAggregateMaturityYearTwo	6000000	USD
CY2021Q4	owlt	Long Term Debt Future Aggregate Maturity Year Three LongTermDebtFutureAggregateMaturityYearThree	2000000	USD
CY2021Q4	owlt	Long Term Debt Future Aggregate Maturity Total LongTermDebtFutureAggregateMaturityTotal	16534000	USD
CY2021Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	3.1546
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2000	USD
CY2021Q4	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	claim
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1541000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1587000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	953000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4081000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1985000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1221000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10215834	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.45
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9899765	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2623689	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.30
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3794486	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.82
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	704672	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.63
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	417866	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.28
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4649000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	740000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1769796	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.75
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3050929	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.71
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	7560	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.12
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	9622	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.63
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10357495	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.87
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10215834	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.45
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6712145	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.73
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6673539	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.30
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17529000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	14775000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M20D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	54135000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M14D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	36326000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y5M19D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2822000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	842000	USD
CY2021	owlt	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	9507000	USD
CY2020	owlt	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue	3879000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.62
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.02
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	10352973	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	17532000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.86
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y11M12D
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4259000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1070000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	8621000	USD
CY2021	owlt	Period Required For Warrants To Become Exercisable Initial Public Offering PeriodRequiredForWarrantsToBecomeExercisableInitialPublicOffering	P12M
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021	owlt	Class Of Warrant Or Right Redemption Period After Warrants Become Exercisable ClassOfWarrantOrRightRedemptionPeriodAfterWarrantsBecomeExercisable	P90D
CY2021Q4	owlt	Common Stock Shares Subject To Vesting CommonStockSharesSubjectToVesting	2807500	shares
CY2021	owlt	Number Of Trading Days NumberOfTradingDays	20	D
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	94973000	USD
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7061000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	16954000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	2993000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-15149000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2214000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2192000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-296000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14864000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1980000	USD
CY2021	owlt	Effective Income Tax Rate Reconciliation Warrant Expense Benefit Amount EffectiveIncomeTaxRateReconciliationWarrantExpenseBenefitAmount	-2067000	USD
CY2020	owlt	Effective Income Tax Rate Reconciliation Warrant Expense Benefit Amount EffectiveIncomeTaxRateReconciliationWarrantExpenseBenefitAmount	410000	USD
CY2021	owlt	Effective Income Tax Rate Reconciliation Convertible Notes Conversion Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesConversionAmount	5473000	USD
CY2020	owlt	Effective Income Tax Rate Reconciliation Convertible Notes Conversion Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesConversionAmount	0	USD
CY2021	owlt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	-941000	USD
CY2020	owlt	Effective Income Tax Rate Reconciliation Transaction Costs Amount EffectiveIncomeTaxRateReconciliationTransactionCostsAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	43000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	140000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	987000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	387000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	740000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	196000	USD
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	780000	USD
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	354000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27339000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14718000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	836000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	212000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	30682000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15867000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30682000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15818000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	49000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30682000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14864000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-71704000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-10521000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63216912	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63216912	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21956848	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21956848	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2021Q4	owlt	Common Stock Shares Subject To Vesting CommonStockSharesSubjectToVesting	2807500	shares
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75842000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75403000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1870000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1718000	USD
CY2021	dei	Auditor Firm AuditorFirmId	238

Files In Submission

Name	View Source	Status
0001628280-22-007346-index-headers.html	Edgar Link	pending
0001628280-22-007346-index.html	Edgar Link	pending
0001628280-22-007346.txt	Edgar Link	pending
0001628280-22-007346-xbrl.zip	Edgar Link	pending
ex-107ninthamendmenttoseco.htm	Edgar Link	pending
ex-211owletincsubsidiaries.htm	Edgar Link	pending
ex-23110xkconsentowlet2021.htm	Edgar Link	pending
ex-311owletinc302certifica.htm	Edgar Link	pending
ex-312owletinc302certifica.htm	Edgar Link	pending
ex-321owletinc906certifica.htm	Edgar Link	pending
ex-322owletinc906certifica.htm	Edgar Link	pending
ex-43xdescriptionofsecurit.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
owlt-20211231.htm	Edgar Link	pending
owlt-20211231.xsd	Edgar Link	pending
owlt-20211231_cal.xml	Edgar Link	unprocessable
owlt-20211231_def.xml	Edgar Link	unprocessable
owlt-20211231_htm.xml	Edgar Link	completed
owlt-20211231_lab.xml	Edgar Link	unprocessable
owlt-20211231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OWLT
Owlet, Inc. Stock $owlt

2021 Q4 Form 10-K Financial Statement

#000162828022007346 Filed on March 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OWLT Owlet, Inc. Stock $owlt

2021 Q4 Form 10-K Financial Statement

#000162828022007346 Filed on March 25, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OWLT
Owlet, Inc. Stock $owlt